Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

Samuel G. Siris; Alene Strahan; John Mandeli; Elaine Casey; Thomas B. Cooper

doi:10.1016/0920-9964(88)90037-0

Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

Samuel G. Siris, Alene Strahan, John Mandeli, Elaine Casey, Thomas B. Cooper

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The authors examined the fluphenazine decanoate dose and the fluphenazine plasma levels in comparison with measures of severity of depression in schizophrenic and schizoaffective patients. All patients were selected for study on the basis of having stable, syndromally defined, antiparkinsonian non-responsive syndromes of post-psychotic depression. No meaningful relationships were found. The implications of this observation with regard to the notion that depressive symptomatology in such patients is neuroleptic-induced is discussed.

Original language	English
Pages (from-to)	31-35
Number of pages	5
Journal	Schizophrenia Research
Volume	1
Issue number	1
DOIs	https://doi.org/10.1016/0920-9964(88)90037-0
State	Published - 1988

Keywords

(Schizophrenia)
Depression
Fluphenazine
Neuroleptic
Post-psychotic depression

Access to Document

10.1016/0920-9964(88)90037-0

Cite this

@article{061ac6b0ddd744bc83d983e5cdaf2457,

title = "Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression",

abstract = "The authors examined the fluphenazine decanoate dose and the fluphenazine plasma levels in comparison with measures of severity of depression in schizophrenic and schizoaffective patients. All patients were selected for study on the basis of having stable, syndromally defined, antiparkinsonian non-responsive syndromes of post-psychotic depression. No meaningful relationships were found. The implications of this observation with regard to the notion that depressive symptomatology in such patients is neuroleptic-induced is discussed.",

keywords = "(Schizophrenia), Depression, Fluphenazine, Neuroleptic, Post-psychotic depression",

author = "Siris, \{Samuel G.\} and Alene Strahan and John Mandeli and Elaine Casey and Cooper, \{Thomas B.\}",

note = "Funding Information: This work was supported by NIMH Grants nos. MH-34309 and MH-03092.",

year = "1988",

doi = "10.1016/0920-9964(88)90037-0",

language = "English",

volume = "1",

pages = "31--35",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

AU - Siris, Samuel G.

AU - Strahan, Alene

AU - Mandeli, John

AU - Casey, Elaine

AU - Cooper, Thomas B.

N1 - Funding Information: This work was supported by NIMH Grants nos. MH-34309 and MH-03092.

PY - 1988

Y1 - 1988

N2 - The authors examined the fluphenazine decanoate dose and the fluphenazine plasma levels in comparison with measures of severity of depression in schizophrenic and schizoaffective patients. All patients were selected for study on the basis of having stable, syndromally defined, antiparkinsonian non-responsive syndromes of post-psychotic depression. No meaningful relationships were found. The implications of this observation with regard to the notion that depressive symptomatology in such patients is neuroleptic-induced is discussed.

AB - The authors examined the fluphenazine decanoate dose and the fluphenazine plasma levels in comparison with measures of severity of depression in schizophrenic and schizoaffective patients. All patients were selected for study on the basis of having stable, syndromally defined, antiparkinsonian non-responsive syndromes of post-psychotic depression. No meaningful relationships were found. The implications of this observation with regard to the notion that depressive symptomatology in such patients is neuroleptic-induced is discussed.

KW - (Schizophrenia)

KW - Depression

KW - Fluphenazine

KW - Neuroleptic

KW - Post-psychotic depression

UR - https://www.scopus.com/pages/publications/0023824750

U2 - 10.1016/0920-9964(88)90037-0

DO - 10.1016/0920-9964(88)90037-0

M3 - Article

C2 - 3154504

AN - SCOPUS:0023824750

SN - 0920-9964

VL - 1

SP - 31

EP - 35

JO - Schizophrenia Research

JF - Schizophrenia Research

IS - 1

ER -

Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

Abstract

Keywords

Access to Document

Fingerprint

Cite this